*Thymus vulgaris* is a species of ever green plant in the Lamiaceae family originated from Mediterranean regions and has been adapted to many different climates around the world. It is a bushy, woody based shrub, 10 to 40 cm high with small and highly aromatic gray-green oval leaves containing numerous small glands with clusters of pink or purple flowers. The genus *Thymus* comprises approximately 400 species, several of which are widely used in traditional medicine.^[@bibr1-2156587217700772],[@bibr2-2156587217700772]^ *Thymus vulgaris* is the most important species and traditionally has been administered for whooping cough, bronchitis, laryngitis gastritis, upper respiratory congestion, and diarrhea. *Thymus vulgaris* leaves oil or extract has also been used in the treatment of sore throat, tonsillitis, gum diseases, rheumatism, and arthritis.^[@bibr3-2156587217700772][@bibr4-2156587217700772]--[@bibr5-2156587217700772]^ This essential oil has been considered as an antiseptic, antimicrobial, antispasmodic, antioxidant, and antitussive agent. There have been a number of reports validating the in vitro antibacterial and antifungal activities of this essential oil on some human pathogens, including *Staphylococcus aureus*, *Pseudomonas aeruginosa*, *Escherichia coli*, *Candida albicans*, *Mycobacterium smegmatis*, *Proteus mirabilis*, *Propionebacterium acnes*, and *Salmonella* species.^[@bibr6-2156587217700772][@bibr7-2156587217700772][@bibr8-2156587217700772][@bibr9-2156587217700772][@bibr10-2156587217700772]--[@bibr11-2156587217700772]^ The main constituents of *Thymus vulgaris* leaves essential oil are 2 phenolic compounds, thymol (2-isopropyl-5-methylphenol) and its conformational isomer, carvacrol (5-isopropyl-2-methylphenol). Further components in the essential oil are thymol methyl ether, cineol, cymene, α-pinene, and borneol.^[@bibr10-2156587217700772],[@bibr12-2156587217700772]^ The antimicrobial activities of *Thymus vulgaris* oil is mostly believed to be related to the thymol and carvacrol contents of the oil.

Dental caries, periodontal diseases, and streptococcal pharyngitis are the most common oral infectious diseases of man. Dental caries is a multifactorial condition in which diet, nutrition, resident microbial oral flora, and the host responses interact to determine whether infection occurs. *Streptococcus mutans* and *Streptococcus sobrinus* are known as the main etiological agents of dental caries. These endogenous cariogenic bacteria adhere and colonize the tooth surface and produce a sticky glycocalyx film composed of glucan resulting from the action of *Streptococcal* glucosyl transferase on dietary carbohydrates (mainly sucrose). Accumulation of bacteria on the enamel causes dental plaques formation within which there is continuing acid production by bacterial plaques, which causes demineralization of enamel and consequently leads to caries formation.^[@bibr13-2156587217700772]^

Periodontitis is a chronic, slowly progressive polymicrobial infectious disease that affects the entire tooth and supporting tissues. In this infection, the gingival crevice enlarges to become a "pocket" with local inflammation. Periodontal disease is characterized by destruction of periodontal ligaments, alveolar bone, and gingival pocket formation, which consequently leads to tooth loss. This infection is known to be caused by *Aggregatibacter actinomycetemcomitans*, *Prevotella intermedia*, *Porphyromonas gingivalis*, and *Tannerlla forythus*, which are frequently isolated from gingival pocket and subgingival plaques of patients with periodontitis.^[@bibr14-2156587217700772]^

Streptococcal pharyngitis is a bacterial infection of oropharynx that affects tonsils and possibly larynx and characterized by fever, sore throat, cervical lymphadenopathy, and tonsillar exudates. This infection is caused by Group A, β-hemolytic *Streptococci* or *Streptococcus pyogenes*. Although untreated *Streptococcal* pharyngitis usually resolves within a few days, antibiotic treatment will shorten the acute illness by about 16 hours, and hence reduce the risk of post--streptococcal pharyngitis complications such as rheumatic fever and glomerulonephritis. Although penicillin has long been regarded as the treatment of choice in tonsillopharyngitis caused by *S pyogenes*, since late 1970, bacteriological and clinical failure rate with penicillin therapy begun to increase, ranging from 2% to 30% among these patients and asymptomatic carriers.^[@bibr15-2156587217700772][@bibr16-2156587217700772][@bibr17-2156587217700772]--[@bibr18-2156587217700772]^ Erythromycin and related macrolide antibiotics are considered as an alternative among patients with allergy to penicillin.^[@bibr19-2156587217700772]^ However, increasing incidence of erythromycin resistance has also been reported in several parts of the world.^[@bibr20-2156587217700772]^ It is therefore essential to discover new antibacterial agents to combat strains expressing resistance to available antibiotics.

Although the in vitro antimicrobial activity of *Thymus vulgaris* leaves essential oil on some human pathogens are widely documented, the effects of this oil on oral pathogens such as periodontopathic and cariogenic microorganisms are not fully understood. In the present study, we are reporting in vitro inhibitory activity of *Thymus vulgaris* oil on some clinical isolates of oral pathogens, including *Streptococcus pyogenes*, *Streptococcus mutans*, *Candida albicans*, *Aggregatibacter actinomycetemcomitans*, and *Porphyromonas gingivalis*.

Materials and Methods {#section1-2156587217700772}
=====================

Preparation of Thymus vulgaris Oil {#section2-2156587217700772}
----------------------------------

Fresh *Thymus vulgaris* were purchased from the local market and were kept in dark at room temperature. One hundred grams of dried leaves was crashed and extracted by conventional steam distillation using a Clevenger apparatus for 3 hours, and condensation took place continuously at 4°C in cold water. The essential oil was then dried over sodium sulfate (Sigma-Aldrich, St Quentin-Fallaveier, France) and stored at 4°C in dark vials until used. The aforementioned experiment was repeated 3 times and the mean of the yield ± standard deviation was recorded. A 1 mg/mL solution of *Thymus vulgaris* oil was prepared in 10% aqueous dimethyl sulfoxide containing 0.5% Tween 80 (for easy diffusion) and used as stock solution for determination of antimicrobial activities of this oil.

Isolation of Streptococcus pyogenes (β-Hemolytic Streptococci Group A) {#section3-2156587217700772}
----------------------------------------------------------------------

Suspected patients with pharyngitis, mostly children below 10 years of age, were examined, and exudates were obtained from the posterior part of the pharynx using sterile cotton swabs. The swabs were then cultured on sheep blood agar (SBA) plates and kept at 37°C, 5% CO~2~, for 48 hours. The suspicious colonies with β-hemolysis were subjected to the bacitracin sensitivity test by using a 0.04 mg disk for identification of *S pyogenes*. Pure cultures of each strain isolated from the patients were obtained on sheep blood agar plates and kept at 4°C until used.^[@bibr21-2156587217700772]^

Isolation of Streptococcus mutans From Carious Teeth {#section4-2156587217700772}
----------------------------------------------------

*Streptococcus mutans* was isolated from carious teeth as described previously.^[@bibr21-2156587217700772][@bibr22-2156587217700772]--[@bibr23-2156587217700772]^ Briefly, the extracted carious teeth were incubated in 10 mL Todd-Hewitt Broth (THB) (Merck, Germany) at 37°C, 5% CO~2~, for 48 hours. A Mitis-Salivarious-Bacitracin-Agar (MSBA) was subcultured from THB and incubated at 37°C, 5% CO~2~, for 72 hours. *S mutans* was identified by standard bacteriological and biochemical procedures, including colony morphology (greenish hemolysis), catalase, Voges-Proskauer, arginine dihydrolase, hippurate hydrolysis, and fermentation of glucose, manitol, raffinose, melobiose, and sorbitol.^[@bibr23-2156587217700772][@bibr24-2156587217700772]--[@bibr25-2156587217700772]^ Pure culture of each clinical isolate of *S mutans* was obtained on MSBA medium and kept at 4°C until used.

Isolation of Periodontopathic Bacteria {#section5-2156587217700772}
--------------------------------------

Patients with either aggressive or localized aggressive periodontitis were examined and sampled for isolation of *A actinomycetemcomitans* and *P gingivalis.* ^[@bibr21-2156587217700772],[@bibr22-2156587217700772],[@bibr26-2156587217700772]^ Subgingival pocket samples were taken from the deepest part of periodontal pocket (probing depth ≥6 mm) by insertion of sterile paper point (Iso 35, Bocht, Offenburg, Germany). Each sample was inoculated into 4 mL Trypticase Soy Broth (TSB) containing 5 μg/mL of hemin and menadione (Becton Dickinson Microbiology System) and kept under anaerobic condition at 37°C, 5% CO~2~, for 48 hours. Bacteria from TSB were subcultured on Trypticase Soy-Blood Agar (TSBA) plates (composed of 40 g/L Trypticase soy agar, 5 mg/L hemin,10 mg/L *N*-acetylmuramic, acid and 50 mL/L defibrinated sheep blood) and kept under anaerobic condition at 37°C, 5% CO~2~, for 72 hours. *A actinomycetemcomitans* and *P gingivalis* were identified according to our previous publications.^[@bibr21-2156587217700772],[@bibr22-2156587217700772],[@bibr26-2156587217700772]^ Pure culture of each clinical isolates was prepared on TSBA and kept at 4°C until used.

Isolation of Candida albicans {#section6-2156587217700772}
-----------------------------

Patients with denture stomatitis, oral candidiasis, and infected root canal were sampled and cultured on Sabouraud dextrose agar (SDA) and kept at 37°C for 72 hours. *C albicans* was diagnosed on the basis of colonial morphology and other conventional mycological procedures.^[@bibr10-2156587217700772],[@bibr21-2156587217700772]^ Pure cultures of *C albicans* were prepared on SDA and kept at 4°C until used. In the present study, 30 strains of each of *S mutans*, *A actinomycetemcomitans*, *P gingivalis*, *C albicans*, and *S pyogenes* isolated from patients with various oral infections were used for *Thymus vulgaris* oil antimicrobial determination by standard assays.

Agar Disk Diffusion {#section7-2156587217700772}
-------------------

The antibacterial activities of *Thymus vulgaris* oil were determined by the standard disk diffusion susceptibility test on solid media. MSBA plates were used for *S mutans*, SBA plates for *S pyogenes*, SDA for *C albicans*, and TSBA for *A actinomycetemcomitans* and *P gingivalis*. *S mutans* ATCC 25175, *A actinomycetemcomitans* ATCC 29523, strains which were maintained anaerobically on TSBA supplemented with 10% defibrinated horse blood and hemin (5 μg/mL; Wako Pure Chemical Industries, Osaka, Japan), and *C albicans* ATCC10231 were used as control.

Pure microbial cell suspensions of each clinical isolates were obtained in 5 mL THB for *S mutans* and *S pyogenes*, TSB for *A actinomycetemcomitans* and *P gingivalis*, and Sabouraud dextrose broth (SDB) for *C albicans*. The suspension turbidity of these microorganisms was adjusted to 1.5 × 10^8^ colony forming unit/mL (\# 0.5 McFarland) and 100 μL of this suspension was seeded on appropriate solid culture media. A 6-mm-diameter sterile Whatman filter paper No. 5 (round filter Machery-Nagel, Doren, Germany) was impregnated with 50 μL of various concentrations of *Thymus vulgaris* oil and placed on the aforementioned culture media, followed by incubation at 37°C for 72 hours. Sabouraud dextrose agar containing *C albicans* was incubated at 37°C for 72 hours. The growth inhibition zones around the filter paper were measured in millimeters; means and standard deviations were calculated and recorded. Those disks containing *Thymus vulgaris* oil that did not produced inhibition zones were considered negative results. Sterile filter paper soaked in 50 μL of 10% dimethyl sulfoxide and antibiotic disks of vancomycin (30 μg), amikacin (30 μg), and nystatin (25 μg) were also used as control.

Determination of Minimum Inhibitory Concentration of Thymus vulgaris Oil {#section8-2156587217700772}
------------------------------------------------------------------------

The minimum inhibitory concentration of *Thymus vulgaris* oil against bacterial and fungal (*C albicans*) isolates from oral infections was carried out by broth microdilution method using 96-well cell culture plates^[@bibr27-2156587217700772]^ (Greiner Bio-One, Bergamo Italy). Todd-Hewitt Broth was used for *S mutans* and *S pyogenes*, SDB broth for *C albicans*, and TSB containing hemin and menadione (5 μg/mL) for *A actinomycetemcomitans* and *P gingivalis*. Cell suspensions of the clinical isolates were prepared in the appropriate liquid culture media and their concentrations were adjusted to 10^7^ colony forming units/mL. Two-fold dilutions of *Thymus vulgaris* oil were prepared from the stock solution. Aliquots (100 μL) of each dilution of *Thymus vulgaris* oil were dispensed in 96-well cell culture plates. One hundred microliters of each bacterial suspension was added to each well and incubated under anaerobic conditions at 37°C, 5% CO~2~, for 48 hours. Microplates containing *C albicans* were incubated under aerobic condition at 37°C for 48 hours. The absorbance was then measured at 595 nm and the highest dilution at which no growth (OD ≤ 0.05) observed was defined as the minimum inhibitory concentration. All experiments were done in triplicates, and means ± standard deviations were recorded.

Statistical Analysis {#section9-2156587217700772}
--------------------

Statistical analysis was performed by the χ^2^ and Fisher's exact tests using the SPSS software package, version 11.5.

Results {#section10-2156587217700772}
=======

The average yield of *Thymus vulgaris* essential oil on the basis of 3 successive extractions by hydrodistillation was 1.6 ± 0.34 g oil/100 g dried leaves. The oil was clear light yellow with pleasant odor. The results of agar disk diffusion assay regarding the growth inhibition zones (mean ± standard deviation) of the tested isolates against various concentrations (256 to 2 μg/mL) of *Thymus vulgaris* oil are summarized in [Table 1](#table1-2156587217700772){ref-type="table"}. In this test, inhibition zones above 6 mm in diameter were taken as positive results. At the concentrations of 64 to 256 μg/mL, all (100%) the microbial isolates were found sensitive and produced inhibition zones ranging from 7.5 ± 0 to 42 ± 0.8 mm in diameter. *S pyogenes* was the most sensitive isolate since all (100%) of these clinical isolates produced the widest inhibition zones against all *Thymus vulgaris* oil concentrations (4-256 μg/mL). On the other hand, all strains (100%) of *S pyogenes* (n = 30), *S mutans* (n = 30), and *C albicans* (n = 30) were sensitive to the 32 μg/mL dose of *Thymus vulgaris* oil, producing inhibition zones ranging from 10.5 to 12.7 mm, while 40% (12/30) of *P gingivalis* and 60% (18/30) of *A actinomycetemcomitans* were sensitive to this oil concentration. None of the clinical isolates in this study showed inhibition zones against 2 μg/mL or lower concentration of *Thymus vulgaris* oil. Agar disk diffusion test carried out on 10% dimethyl sulfoxide showed no inhibitory activity on oral pathogens used in this study ([Figure 1](#fig1-2156587217700772){ref-type="fig"}). The results of minimum inhibitory concentrations of *Thymus vulgaris* oil as measured by broth microdilution method are summarized in [Table 2](#table2-2156587217700772){ref-type="table"}. *S pyogenes* with the minimum inhibitory concentration 1.9 ± 0.2 μg/mL followed by *S mutans* with minimum inhibitory concentration 3.6 ± 0.9 μg/mL were the most sensitive microorganism tested. The minimum inhibitory concentration of *Thymus vulgaris* oil on *C albicans*, *P gingivalis*, and *A actinomycetemcomitans* isolates were 16.3 ± 4, 32 ± 0, and 32 ± 0 μg/mL, respectively. *Thymus vulgaris* oil minimum inhibitory concentration on standard strains of *S mutans* (ATCC 25175), *C albicans* (ATCC 10231), and *A actinomycetemcomitans* (ATCC 29523) were 16 ± 0, 32 ± 0, and 32 ± 0 μg/mL, respectively.

###### 

Antimicrobial Activity of *Thymus vulgaris* Oil on Some Clinically Isolated Oral Pathogens by Agar Disk Diffusion Tests^a^.

![](10.1177_2156587217700772-table1)

  *Thymus vulgaris* Oil (μg/mL)   *Streptococcus pyogenes* (n = 30)   *Streptococcus mutans* (n = 30)   *Candida albicans* (n = 30)   *Porphyromonas gingivalis* (n = 30)   *Aggregatibacter actinomycetemcomitans* (n = 30)
  ------------------------------- ----------------------------------- --------------------------------- ----------------------------- ------------------------------------- --------------------------------------------------
  256                             42 ± 0.8 (100%)                     38.1 ± 1 (100%)                   37.4 ± 1 (100%)               29.9 ± 0.8 (100%)                     32.7 ± 0.7 (100%)
  128                             29.4 ± 0.8 (100%)                   29.2 ± 1 (100%)                   29.8 ± 0.7 (100%)             16.9 ± 0.8 (100%)                     24.4 ± 0.7 (100%)
  64                              21.1 ± 0.8 (100%)                   18.9 ± 1 (100%)                   18.3 ± 0.7 (100%)             9.5 ± 0.5 (100%)                      16.7 ± 1 (100%)
  32                              12.7 ± 1.3 (100%)                   11.7 ± 1 (100%)                   10.5 ± 0.7 (100%)             8.2 ± 0.4 (40%)                       10.9 ± 0.9 (60%)
  16                              9.6 ± 0.8 (100%)                    9.1 ± 0.6 (76.6%)                 8.7 ± 0.6 (36.6%)             7.5 ± 0 (16.6%)                       8 ± 0.7 (26.6%)
  8                               8.8 ± 0.8 (80%)                     8 ± 0.2 (50%)                     0 ± 0 (0%)                    0 ± 0 (0%)                            0 ± 0 (0%)
  4                               8.1 ± 0.3 (26.6%)                   0 ± 0 (0%)                        0 ± 0 (0%)                    0 ± 0 (0%)                            0 ± 0 (0%)
  2                               R                                   R                                 R                             R                                     R
  Vancomycin                      21.5 ± 0.8                          21.2 ± 0.9                        R                             R                                     R
  Amikacin                        R                                   R                                 R                             9.8 ± 0.7                             9.1 ± 0.2
  Nystatin                        R                                   R                                 18\. ± 0.8                    R                                     R
  10% DMSO                        R                                   R                                 R                             R                                     R

Abbreviations: R, resistance (no inhibition zone); DMSO, dimethyl sulfoxide. Vancomycin disk (30 μg), amikacin disk (30 μg), nystatin disk (25 μg).

^a^Data presented are inhibition zone diameter in mm (Mean ± SD). The values in parentheses are sensitivity percentages.

![Agar disk diffusion tests showing inhibition zone around disk containing various concentrations of *Thymus vulgaris* extract.](10.1177_2156587217700772-fig1){#fig1-2156587217700772}

###### 

Minimum Inhibitory Concentration of *Thymus vulgaris* Oil on Some Clinically Isolated Oral Pathogens by Broth Microdilution Method^a^.

![](10.1177_2156587217700772-table2)

  Antimicrobials   *Streptococcus pyogenes* (n = 30)   *Streptococcus mutans* (n = 30)   *Candida albicans* (n = 30)   *Porphyromonas gingivalis* (n = 30)   *Aggregatibacter actinomycetemcomitans* (n = 30)
  ---------------- ----------------------------------- --------------------------------- ----------------------------- ------------------------------------- --------------------------------------------------
  TVO              3.6 ± 0.9                           1.9 ± 0.2                         16.3 ± 4                      32 ± 0                                32 ± 0
  Vancomycin       0.95 ± 0.5                          0.66 ± 0.2                        R                             R                                     R
  Amikacin         R                                   R                                 R                             29.1 ± 1.9                            24.1 ± 1.8
  Nystatin         R                                   R                                 15 ± 1.7                      R                                     R
  10% DMSO         R                                   R                                 R                             R                                     R

Abbreviations: TVO, *Thymus vulgaris* oil; R, resistance; DMSO, dimethyl sulfoxide.

^a^Data presented are minimum inhibitory concentration in μg/mL (mean ± SD).

Discussion {#section11-2156587217700772}
==========

Data presented in this study revealed strong inhibitory activity of *Thymus vulgaris* oil on some oral pathogens, including *S pyogenes*, *S mutans*, *C albicans*, *A actinomycetemcomitans*, and *P gingivalis* as measured by agar disk diffusion and broth microdilution methods. *S pyogenes* isolated from patients with pharyngitis were the most sensitive strains to *Thymus vulgaris* oil as they produced the widest growth inhibition zones (42 ± 0.8 mm) and lowest minimum inhibitory concentration (1.9 ± 0.2 μg/mL). Sfeir et al^[@bibr28-2156587217700772]^ using the same techniques found *S pyogenes* highly sensitive to *Thymus vulgaris* oil with growth inhibition zone of 38 mm and minimum inhibitory concentration as low as 0.87 μg/mL. The antimicrobial activity of various thymus species essential oils on oral *Streptococci* were documented by Nikolic et al.^[@bibr10-2156587217700772]^ *Thymus serpyllum* oil showed strongest activity against *S pyogenes* clinical isolates with minimum inhibitory concentration of 2.5 ± 0.23 μg/mL, while *Thymus vulgaris* oil exhibited lower activity against *S pyogenes* with minimum inhibitory concentration of 80 μg/mL.^[@bibr10-2156587217700772]^ Moreover, these investigators have reported stronger activity of *T serpyllum* oil than streptomycin and ampicillin against *S pyogenes* as measured by minimum inhibitory concentration determinations. Solano et al^[@bibr29-2156587217700772]^ reported that *S pyogenes* isolates produced wider growth inhibition zones (34 mm) against *Thymus vulgaris* oil versus 6-unit penicillin disk, which produced 24 mm inhibition zones. In vitro antibacterial activity of *Thymus vulgaris* vapor against *S pyogenes* is also documented.^[@bibr30-2156587217700772]^ Considering the strong inhibitory activity of *Thymus vulgaris* oil against *S pyogenes* as presented in our study and others,^[@bibr10-2156587217700772],[@bibr28-2156587217700772][@bibr29-2156587217700772]--[@bibr30-2156587217700772]^ it seems reasonable to use this essential oil in aromatherapy, particularly among patients with respiratory tract infections caused by *S pyogenes* such as tonsillitis, pharyngitis, sinusitis, and bronchitis.

Ghorab et al^[@bibr2-2156587217700772]^ reported that incubation of *S mutans*, the main etiologic agent of dental caries, with 20% *Thymus vulgaris* oil resulted in 96% growth inhibition of this bacteria after 48 hours. Moreover, significant reduction of *S mutans* adherence to buccal epithelial cells after mouth washing with 20% *Thymus vulgaris* oil has been observed.^[@bibr31-2156587217700772]^ Nikolic et al^[@bibr10-2156587217700772]^ found *Thymus vulgaris* oil less effective against *S mutans* than *Thymus serpyllum*, as this oil revealed higher minimum inhibitory concentration (160 ± 4.61 μg/mL). Data presented in our study exhibit strong inhibitory activity of *Thymus vulgaris* oil with minimum inhibitory concentration of 3.6 ± 0.9 μg/mL on *S mutans* clinical isolates. On the contrary, Babpour et al^[@bibr32-2156587217700772]^ have detected no inhibitory effects of methanolic and aqueous *Thymus vulgaris* extract on *S mutans* even at concentrations over 500 μg/mL. Very weak inhibitory activity of *Thymus vulgaris* oil with minimum inhibitory concentration of 2670 μg/mL on oral *Streptococci* were also reported by Imelouane et al.^[@bibr9-2156587217700772]^ *Thymus vulgaris* oil analysis by gas chromatography-mass spectrometry carried out by these investigators exhibited no carvacrol and presence of very low amount of thymol (0.24%). These 2 phenolic compounds play major roles in bacterial growth inhibition, and therefore, these findings may be an explanation for the weak (high value of minimum inhibitory concentration) or no inhibitory activity of *Thymus vulgaris* oil on oral *Streptococci* as reported by the investigators.^[@bibr9-2156587217700772]^ Denture-related stomatitis is a very common form of oral candidiasis and is referred to as mild inflammation and erythema of mucosa beneath a denture. In our study *C albicans* isolated from patients with denture stomatitis (21/30) and infected root canal from patients with advanced periodontitis (9/30) were all sensitive to *Thymus vulgaris* oil with mean minimum inhibitory concentration of 16.3 ± 4 μg/mL. Minimum inhibitory concentrations values of the oil as low as 1.62 ± 0 μg/mL^3^ to as high as 3300 μg/mL^5^ for clinical isolates of *C albicans* are documented by other investigators*. Aggregatibacter actinomycetemcomitans* and *Porphyromonas gingivalis* are the 2 anaerobic gram negative rods that are the most prevalent etiological agents of periodontal diseases. Data on the inhibitory activity of *Thymus vulgaris* oil on these periodontopathic bacteria are very limited in the literature. In our study, *A actinomycetemcomitans* and *P gingivalis* clinical isolates were sensitive to *Thymus vulgaris* oil with mean minimum inhibitory concentration 32 μg/mL; however, higher value of *Thymus vulgaris* oil minimum inhibitory concentration (62.5 mg/mL) on these periodontopathic bacteria are reported by other investigators.^[@bibr33-2156587217700772]^ These discrepancies in minimum inhibitory concentration values reported by different investigators from various regions are mainly attributed to the fact that *Thymus vulgaris* oil chemical composition and active ingredients' (thymol, carvacrol, P-cymene, etc) concentrations are greatly determined by the plant genotype and influence of environmental factors including geographical conditions, nature of soil, temperature, season of collection and harvesting plant, and more important, the oil extraction procedure.^[@bibr4-2156587217700772],[@bibr9-2156587217700772],[@bibr34-2156587217700772][@bibr35-2156587217700772][@bibr36-2156587217700772]--[@bibr37-2156587217700772]^ Much of the antimicrobial activities of *Thymus vulgaris* oil appear to be associated with the phenolic compounds thymol and carvacrol.^[@bibr38-2156587217700772]^ Although the mode of action of these compounds are not clearly understood, it is mostly believed that the hydroxyl group on these 2 compounds interacts with the cytoplasmic membrane, changes its permeability, and affects the lipid ordering and stability of its bilayer, resulting in an increase of proton passive flux across the membrane, leading to disruption of cytoplasmic membrane and leakage of cellular contents.^[@bibr38-2156587217700772][@bibr39-2156587217700772][@bibr40-2156587217700772][@bibr41-2156587217700772]--[@bibr42-2156587217700772]^ The antifungal activity of the oil is mostly associated with the direct interaction of thymol, carvacrol, and P-cymene with cytoplasmic membrane ergostrol, which consequently leads to fungal cell membrane disruption and release of the cellular contents.^[@bibr8-2156587217700772],[@bibr12-2156587217700772]^ Most studies reporting the antimicrobial activity of plant essential oils against foodborne and human pathogens agree that essential oils are relatively more active against gram positive than gram negative bacteria.^[@bibr43-2156587217700772]^ Results obtained in our study showed gram positive bacteria were more susceptible to *Thymus vulgaris* oil than the gram negatives as measured by agar disk diffusion and minimum inhibitory concentration determinations. Zaika et al^[@bibr44-2156587217700772]^ proposed that gram positive bacteria were more resistant to the plant volatile oils than to the gram negatives. This is in contrast to the hypothesis proposed by Dean et al,^[@bibr45-2156587217700772]^ who observed little or no differences between gram positive and gram negative bacteria regarding the inhibitory effects of plant essential oils. However, greater susceptibility of gram negatives against *Thymus vulgaris* oil than the gram positive bacteria is documented.^[@bibr9-2156587217700772]^ The greater resistance of gram negatives might be associated with the presence of an outer membrane hydrophilic lipopolysaccharide, which inhibits accumulation of hydrophobic plant essential oil on the cell membrane.^[@bibr46-2156587217700772]^ Consumption of *Thymus vulgaris* flowers and leaves are safe; however, caution is warranted with the use of thyme oil, which should not be taken orally and should be diluted with a suitable oil (olive or almond oil) before use. Side effects of thyme oil if taken orally may include headache, dizziness, low blood pressure, gastrointestinal irritation, nausea, vomiting, and diarrhea.^[@bibr47-2156587217700772]^

Data presented in this study revealed strong in vitro antimicrobial activity of *Thymus vulgaris* oil on clinical isolates of *S pyogenes*, *S mutans*, *C albicans*, *A actinomycetemcomitans*, and *P gingivalis* and therefore might be used in mouth rinse, toothpaste, or aromatherapy for prevention and treatment of related oral infections.
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